Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesHong Kong Pharma Digital Technology Holdings Limited Ordinary shares

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

Healthcare Medical Distribution
PortfolioPortfolio WatchlistWatchlist
Company price
1.94 USD 0.11 ( 6.01%)
Last update at 2026-11-03T21:00:00Z
VOLUME
16631
Market Cap
5.59M

Momentum Score

…

Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services. In addition, it provides value-added services such as labeling, extended storage, product inspection, batch processing, and logistics support, as well as sales of health supplements and non-pharmaceutical products. The company serves e-commerce platform logistics partners, merchants, and Chinese e-commerce platforms as well as pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.74
Low
2.00
High
52 Week Price Range
0.10
Low
1.82
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public disclosures for Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ: HKPD) are limited; the company is associated with pharmaceutical and digital healthcare services. Long‑term growth may be supported by broader adoption of digital health technologies, aging demographics in Greater China, and demand for pharmaceutical distribution and data services. These sector trends could make the company of interest to investors seeking health‑tech exposure, but company‑specific information on operations and financials appears sparse.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
1.83
Dividend Yield
-
Revenue TTM
13.43M
Revenue Per Share
0.57
Gross Profit TTM
1.39M
Debt / Equity
0.13
ROE
-15.59%
Net Debt
1.04M
ROCE
-10.42%
Diluted EPS TTM
-0.06

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Type yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Income before tax -1.13M 0.04M 1.53M 1.02M
Minority interest - - 0.00M 0.00M
Net income -1.14M -0.03M 1.33M 1.00M
Selling general administrative 2.40M 2.22M 1.89M 1.76M
Gross profit 1.39M 2.42M 3.56M 2.74M
Reconciled depreciation 0.69M 1.07M 0.93M 0.71M
Ebit -1.00M 0.13M 1.61M 1.04M
Ebitda -0.92M 1.21M 2.53M 1.76M
Depreciation and amortization 0.09M 1.07M 0.93M 0.71M
Operating income -0.99M 0.13M 1.61M 1.04M
Other operating expenses 14.43M 20.18M 15.08M 11.51M
Interest expense 0.13M 0.10M 0.08M 0.02M
Tax provision 0.01M 0.06M 0.20M 0.02M
Interest income 0.00M 0.00M 0.00M 0.00M
Net interest income -0.13M -0.10M -0.08M -0.02M
Income tax expense 0.01M 0.06M 0.20M 0.02M
Total revenue 13.43M 20.31M 16.69M 12.56M
Total operating expenses 2.38M 2.28M 1.95M 1.70M
Cost of revenue 12.05M 17.90M 13.13M 9.82M
Total other income expense net -0.13M -0.10M -0.08M -0.02M
Net income from continuing ops -1.14M -0.03M 1.33M 1.00M
Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Type yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Total assets 12.84M 9.42M 8.67M 3.41M
Intangible assets 0.08M 0.10M 0.03M 0.00M
Other current assets 7.96M 0.45M 2.53M 0.34M
Total liab 3.26M 4.43M 4.41M 2.82M
Total stockholder equity 9.58M 4.99M 4.25M 0.59M
Other current liab 0.46M 0.10M 0.59M 0.44M
Common stock 0.02M 0.01M 0.01M 0.01M
Capital stock 0.02M 0.01M 0.01M 0.01M
Retained earnings 0.37M 1.50M 1.53M 0.20M
Cash 0.22M 0.75M 0.62M 0.52M
Total current liabilities 3.20M 2.92M 3.18M 2.55M
Current deferred revenue - 0.12M 0.19M 0.27M
Net debt 1.04M 1.63M 1.47M 0.17M
Short term debt 1.19M 0.86M 0.85M 0.42M
Short long term debt 0.88M 0.37M 0.22M 0.06M
Short long term debt total 1.26M 2.37M 2.09M 0.69M
Other stockholder equity 8.95M 3.46M 2.72M 0.38M
Total current assets 12.33M 8.73M 7.80M 2.75M
Short term investments 0.00M 2.26M 0.00M -
Net receivables 3.80M 4.71M 3.72M 1.70M
Long term debt - 1.50M 1.12M 0.12M
Inventory 0.36M 0.56M 0.93M 0.19M
Accounts payable 1.54M 1.73M 1.32M 1.40M
Accumulated other comprehensive income 0.24M 0.01M -0.00M -0.00M
Non current assets total 0.51M 0.69M 0.87M 0.66M
Capital lease obligations 0.38M 0.50M 0.75M 0.51M
Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Type yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Investments 0.90M -2.45M -0.04M -0.13M
Total cashflows from investing activities 0.86M -2.45M -0.04M -0.13M
Net borrowings -0.63M -0.93M 0.37M -1.16M
Total cash from financing activities -0.63M 2.00M 0.54M -1.16M
Net income -1.14M -0.03M 1.33M 1.00M
Change in cash -0.53M 0.12M 0.10M 0.44M
Begin period cash flow 0.75M 0.63M 0.52M 0.08M
End period cash flow 0.22M 0.75M 0.63M 0.52M
Total cash from operating activities -0.75M 0.57M -0.39M 1.73M
Issuance of capital stock 0.00M 4.30M 0.51M 0.00M
Depreciation 0.69M 1.07M 0.93M 0.71M
Other cashflows from investing activities 0.89M -0.09M 0.01M -0.02M
Change to inventory 0.20M 0.38M -0.74M -0.19M
Change to account receivables 0.84M -1.02M -2.09M -0.93M
Other cashflows from financing activities - -1.38M -0.35M -
Capital expenditures 0.04M 0.15M 0.09M 0.12M
Change in working capital 0.73M -0.52M -2.65M 0.01M
Other non cash items -1.03M 0.04M -0.00M 1.19M
Free cash flow -0.79M 0.41M -0.48M 1.61M

Peer Comparison*

Sector: Healthcare Industry: Medical Distribution

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
HKPD
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares		 0.11
6.01%		 1.94 - - 0.42 0.64 0.54 21.89
MCK
McKesson Corporation		 1.53
0.15%		 999.91 24.45 20.41 0.26 5.04 0.27 15.03
COR
Cencora Inc.		 2.73
0.81%		 340.57 24.22 16.39 0.19 20.41 0.21 13.72
CAH
Cardinal Health Inc		 -
-%		 252.94 29.48 17.92 0.20 16.07 0.22 15.67
HSIC
Henry Schein Inc		 -4.12
4.76%		 82.50 25.89 15.08 0.72 3.14 1.00 13.43

Profile*

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services. In addition, it provides value-added services such as labeling, extended storage, product inspection, batch processing, and logistics support, as well as sales of health supplements and non-pharmaceutical products. The company serves e-commerce platform logistics partners, merchants, and Chinese e-commerce platforms as well as pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.

Well Town Industrial Building, Yau Tong, Hong Kong, 999077

852 2618 9289

https://www.9zt.hk

11

Name Title Year Born
Mr. Chenyu Liang CEO & Director 2000
Ms. Shu Liu Chief Financial Officer 1996
Mr. Zifeng Wang Chief Strategy Officer 1972

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

VNP
CAD 32.54
+24.44%
HUT
CAD 88.32
+14.81%
KEEL
CAD 3.05
+14.66%
MTY
CAD 36.63
+13.58%
CNL
CAD 15.98
+11.90%
MOON
CAD 4.72
-12.34%
EU
CAD 0.96
-8.57%
URE
CAD 1.02
-8.48%
AP-UN
CAD 3.71
-8.17%
HG
CAD 3.77
-8.05%

Equity Sectors*

  • Basic Materials

    -1.14%

  • Communication Services

    +0.65%

  • Consumer Cyclical

    +0.09%

  • Consumer Defensive

    -0.57%

  • Energy

    -0.15%

  • Financial Services

    +0.08%

  • Healthcare

    +2.18%

  • Industrials

    +2.04%

  • Real Estate

    -0.25%

  • Technology

    +1.02%

  • Utilities

    +0.66%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…